Overall Survival Analyzer: A software tool to analyze genotyping and clinical data enriched with temporal events

The estimation of survival distributions of patients is an important current problem in clinical oncology. The current trend is to integrate molecular data (such as genomic data) with clinical data (e.g. cancer type, stage of the disease, etc) and then to link survival distributions to molecular profile of patients. Recently, the Affymetrix DMET (Drug Metabolizing Enzymes and Transporters) microarray technology has enabled the possibility to determine the allelic variants of a patient and to relate them to phenotype (e.g. drug toxicity). Therefore, the analysis of survival distribution of patients starting from their profile obtained using DMET data may reveal important knowledge to clinicians. In order to provide support to this analysis we propose Overall Survival Analyzer (OS-Analyzer), a software tool able to compute the Overall Survival and Progression-Free Survival (PFS). The tool is able to perform an automatic analysis of data avoiding wasting time on the manual analysis. OS-Analyzer is available to download at the follows web address: https://sites.google.com/site/overallsurvivalanalyzer/.

[1]  KyungMann Kim,et al.  Contrasting treatment‐specific survival using double‐robust estimators , 2012 .

[2]  Kenta Nakai,et al.  PrognoScan: a new database for meta-analysis of the prognostic value of genes , 2009, BMC Medical Genomics.

[3]  Aedín C. Culhane,et al.  survcomp: an R/Bioconductor package for performance assessment and comparison of survival models , 2011, Bioinform..

[4]  C. Benz,et al.  Optimized high-throughput microRNA expression profiling provides novel biomarker assessment of clinical prostate and breast cancer biopsies , 2006, Molecular Cancer.

[5]  Benjamin E. Gross,et al.  Integrative Analysis of Complex Cancer Genomics and Clinical Profiles Using the cBioPortal , 2013, Science Signaling.

[6]  Kay Nieselt,et al.  Mayday - integrative analytics for expression data , 2010, BMC Bioinformatics.

[7]  Mario Cannataro,et al.  DMET-Analyzer: automatic analysis of Affymetrix DMET Data , 2012, BMC Bioinformatics.

[8]  J. Mesirov,et al.  GenePattern 2.0 , 2006, Nature Genetics.

[9]  Mario Cannataro,et al.  coreSNP: Parallel Processing of Microarray Data , 2014, IEEE Transactions on Computers.

[10]  Baolin Wu,et al.  Network-based Survival Analysis Reveals Subnetwork Signatures for Predicting Outcomes of Ovarian Cancer Treatment , 2013, PLoS Comput. Biol..

[11]  A. Martínez-Torteya,et al.  SurvExpress: An Online Biomarker Validation Tool and Database for Cancer Gene Expression Data Using Survival Analysis , 2013, PloS one.

[12]  R. Tibshirani,et al.  Gene expression patterns of breast carcinomas distinguish tumor subclasses with clinical implications , 2001, Proceedings of the National Academy of Sciences of the United States of America.

[13]  Nikhil Wagle,et al.  High-throughput detection of actionable genomic alterations in clinical tumor samples by targeted, massively parallel sequencing. , 2012, Cancer discovery.

[14]  Mario Cannataro,et al.  Single nucleotide polymorphisms of ABCC5 and ABCG1 transporter genes correlate to irinotecan-associated gastrointestinal toxicity in colorectal cancer patients: A DMET microarray profiling study , 2011, Cancer biology & therapy.

[15]  Shale Dames,et al.  Next generation sequencing for clinical diagnostics-principles and application to targeted resequencing for hypertrophic cardiomyopathy: a paper from the 2009 William Beaumont Hospital Symposium on Molecular Pathology. , 2010, The Journal of molecular diagnostics : JMD.

[16]  L. Feuk,et al.  Detection of large-scale variation in the human genome , 2004, Nature Genetics.

[17]  R. Tibshirani,et al.  Significance analysis of microarrays applied to the ionizing radiation response , 2001, Proceedings of the National Academy of Sciences of the United States of America.

[18]  W. Haenszel,et al.  Statistical aspects of the analysis of data from retrospective studies of disease. , 1959, Journal of the National Cancer Institute.

[19]  T G Clark,et al.  Survival Analysis Part I: Basic concepts and first analyses , 2003, British Journal of Cancer.

[20]  Ming Ouyang,et al.  DNA microarray data imputation and significance analysis of differential expression , 2005, Bioinform..

[21]  E. Kaplan,et al.  Nonparametric Estimation from Incomplete Observations , 1958 .

[22]  Mariamena Arbitrio,et al.  BRCA1/2 genetic background-based therapeutic tailoring of human ovarian cancer: hope or reality? , 2009, Journal of ovarian research.